Published in Arch Ophthalmol on July 01, 1982
The vitelliform macular dystrophy protein defines a new family of chloride channels. Proc Natl Acad Sci U S A (2002) 3.73
Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. Br J Ophthalmol (1995) 3.62
Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium. Proc Natl Acad Sci U S A (2000) 3.32
Structure-function analysis of the bestrophin family of anion channels. J Biol Chem (2003) 2.30
The light peak of the electroretinogram is dependent on voltage-gated calcium channels and antagonized by bestrophin (best-1). J Gen Physiol (2006) 2.18
The lipofuscin component A2E selectively inhibits phagolysosomal degradation of photoreceptor phospholipid by the retinal pigment epithelium. Proc Natl Acad Sci U S A (2002) 2.18
Genetic factors of age-related macular degeneration. Prog Retin Eye Res (2004) 2.17
Outer retinal structure in best vitelliform macular dystrophy. JAMA Ophthalmol (2013) 2.15
Predictive value of fundus autofluorescence for development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci (2006) 1.92
New best1 mutations in autosomal recessive bestrophinopathy. Retina (2015) 1.75
The susceptibility of the retina to photochemical damage from visible light. Prog Retin Eye Res (2011) 1.67
iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration. Hum Mol Genet (2012) 1.59
Functional roles of bestrophins in ocular epithelia. Prog Retin Eye Res (2009) 1.52
Lipofuscin and autofluorescence metrics in progressive STGD. Invest Ophthalmol Vis Sci (2009) 1.38
Detailed analysis of retinal function and morphology in a patient with autosomal recessive bestrophinopathy (ARB). Doc Ophthalmol (2008) 1.33
Quantitative evaluation of fundus autofluorescence imaged "in vivo" in eyes with retinal disease. Br J Ophthalmol (2000) 1.29
Genotype-phenotype correlation and longitudinal course in ten families with Best vitelliform macular dystrophy. Graefes Arch Clin Exp Ophthalmol (2006) 1.21
The genetics of inherited macular dystrophies. J Med Genet (2003) 1.14
Suppression of Ca2+ signaling in a mouse model of Best disease. Hum Mol Genet (2010) 1.14
Quantitative fundus autofluorescence in healthy eyes. Invest Ophthalmol Vis Sci (2013) 1.11
Three-dimensional distribution of the vitelliform lesion, photoreceptors, and retinal pigment epithelium in the macula of patients with best vitelliform macular dystrophy. Arch Ophthalmol (2011) 1.06
Multimodal fundus imaging in Best vitelliform macular dystrophy. Graefes Arch Clin Exp Ophthalmol (2010) 0.99
Quantitative fundus autofluorescence and optical coherence tomography in best vitelliform macular dystrophy. Invest Ophthalmol Vis Sci (2014) 0.97
Electrophysiology of type II mesangiocapillary glomerulonephritis with associated fundus abnormalities. Br J Ophthalmol (1993) 0.97
Retinal pigment epithelial acid lipase activity and lipoprotein receptors: effects of dietary omega-3 fatty acids. Trans Am Ophthalmol Soc (2002) 0.95
Melanoregulin (MREG) modulates lysosome function in pigment epithelial cells. J Biol Chem (2009) 0.92
Clinicopathologic findings in Best vitelliform macular dystrophy. Graefes Arch Clin Exp Ophthalmol (2010) 0.91
Interaction of bestrophin-1 and Ca2+ channel β-subunits: identification of new binding domains on the bestrophin-1 C-terminus. PLoS One (2011) 0.91
Reproducibility of fundus autofluorescence measurements obtained using a confocal scanning laser ophthalmoscope. Br J Ophthalmol (1999) 0.89
[Best's disease. Overview of pathology and its causes]. Ophthalmologe (2005) 0.88
Phenotypic variability due to a novel Glu292Lys variation in exon 8 of the BEST1 gene causing best macular dystrophy. Arch Ophthalmol (2009) 0.88
Macular translocation in a patient with adult-onset foveomacular vitelliform dystrophy with light- and electron-microscopic observations on the surgically removed subfoveal tissue. Graefes Arch Clin Exp Ophthalmol (2004) 0.86
Modeling retinal degenerative diseases with human iPS-derived cells: current status and future implications. Expert Rev Ophthalmol (2013) 0.83
Multimodal analysis of the progression of Best vitelliform macular dystrophy. Mol Vis (2014) 0.79
Dark adaptation in patients with Best vitelliform macular dystrophy. Br J Ophthalmol (1994) 0.79
Maintaining ocular safety with light exposure, focusing on devices for optogenetic stimulation. Vision Res (2016) 0.77
North Carolina macular dystrophy: clinicopathologic correlation. Trans Am Ophthalmol Soc (2001) 0.77
Pattern ERG and psychophysical functions in Best's disease. Doc Ophthalmol (2001) 0.75
Macular translocation in adult-onset vitelliform macular dystrophy: a therapy to be recommended? Graefes Arch Clin Exp Ophthalmol (2004) 0.75
Functional assessment of the fundus autofluorescence pattern in Best vitelliform macular dystrophy. Graefes Arch Clin Exp Ophthalmol (2015) 0.75
Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol (1989) 6.53
Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophthalmol (1982) 6.39
Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch Ophthalmol (1981) 5.09
Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol (1984) 4.68
Age-related macular degeneration. Surv Ophthalmol (1988) 4.18
Ocular explosion after peribulbar anesthesia: case report and experimental study. Ophthalmology (1997) 3.59
Morphologic changes in the lamina cribrosa correlated with neural loss in open-angle glaucoma. Am J Ophthalmol (1983) 3.42
Ocular explosions from periocular anesthetic injections: a clinical, histopathologic, experimental, and biophysical study. Ophthalmology (1999) 3.35
Senile macular degeneration: a case-control study. Am J Epidemiol (1983) 3.04
Foveolar choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci (1998) 3.01
Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res (1983) 2.90
Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group. Arch Ophthalmol (1990) 2.78
Pathologic features of senile macular degeneration. Ophthalmology (1985) 2.73
Assessment of neonatal conjunctivitis with a direct immunofluorescent monoclonal antibody stain for Chlamydia. JAMA (1986) 2.69
Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. Am J Ophthalmol (1982) 2.61
Chronic human glaucoma causing selectively greater loss of large optic nerve fibers. Ophthalmology (1988) 2.59
Brief report: uveitis caused by Tropheryma whippelii (Whipple's bacillus) N Engl J Med (1995) 2.47
Conjunctival lesions in adults. A clinical and histopathologic review. Cornea (1987) 2.43
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch Ophthalmol (2001) 2.41
Unilateral Duane's retraction syndrome (Type 1). Arch Ophthalmol (1982) 2.40
Long-term follow-up of central serous chorioretinopathy. Br J Ophthalmol (1984) 2.40
Epiretinal and vitreous membranes. Comparative study of 56 cases. Arch Ophthalmol (1981) 2.34
Ocular and orbital involvement in leukemia. Surv Ophthalmol (1983) 2.26
Rapidly progressive outer retinal necrosis in the acquired immunodeficiency syndrome. Am J Ophthalmol (1990) 2.25
Senile macular degeneration: a histopathologic study. Trans Am Ophthalmol Soc (1977) 2.20
Histologic characteristics of filtering blebs in glaucomatous eyes. Arch Ophthalmol (1983) 2.19
Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis. Am J Ophthalmol (1999) 2.18
Clinicopathologic correlation of a macular hole treated by cortical vitreous peeling and gas tamponade. Ophthalmology (1994) 2.16
Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol (1989) 2.16
Pathologic findings in pathologic myopia. Retina (1992) 2.14
Lesions of the caruncle: a clinicohistopathologic study. Surv Ophthalmol (1979) 2.08
Bilateral Duane's retraction syndrome. A clinical-pathologic case report. Arch Ophthalmol (1980) 2.01
The histology of human glaucoma cupping and optic nerve damage: clinicopathologic correlation in 21 eyes. Ophthalmology (1979) 1.97
Natural course of choroidal neovascular membranes within the foveal avascular zone in senile macular degeneration. Am J Ophthalmol (1982) 1.97
Histologic studies of the vasculature of the anterior optic nerve. Am J Ophthalmol (1976) 1.96
X-linked ocular albinism. An oculocutaneous macromelanosomal disorder. Arch Ophthalmol (1976) 1.94
Primary adenocarcinoma of the lacrimal gland. A retrospective study. Ophthalmology (1993) 1.93
A histopathologic review of 168 cases of preretinal membrane. Am J Ophthalmol (1977) 1.93
Clinicopathologic study of bilateral macular holes treated with pars plana vitrectomy and gas tamponade. Retina (1992) 1.91
Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol (1997) 1.90
Detection of herpes simplex viral DNA in the iridocorneal endothelial syndrome. Arch Ophthalmol (1994) 1.88
White centered hemorrhages: their significance. Ophthalmology (1980) 1.88
Epibulbar tumors in childhood. Am J Ophthalmol (1975) 1.88
Sebaceous gland carcinoma. Review of 40 cases. Arch Ophthalmol (1984) 1.83
Neurotoxic effects of cisplatin therapy. Arch Neurol (1982) 1.83
Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology (1989) 1.76
Leber hereditary optic neuropathy. Electron microscopy and molecular genetic analysis of a case. Ophthalmology (1995) 1.74
Senile disciform degeneration of the macula. Retinal arterialization of the fibrous plaque demonstrated clinically and histopathologically. Arch Ophthalmol (1971) 1.74
Prognosis of patients with bilateral macular drusen. Ophthalmology (1984) 1.73
Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. Retina (1994) 1.72
Transforming growth factor beta. A biologic chorioretinal glue. Arch Ophthalmol (1989) 1.71
Retinal pathologic changes in multiple sclerosis. Retina (1994) 1.71
Psychophysical evidence for rod vulnerability in age-related macular degeneration. Invest Ophthalmol Vis Sci (2000) 1.67
Posterior capsule opacification in pseudophakic eyes. Ophthalmology (1983) 1.66
Combined hamartomas of the retina and retinal pigment epithelium. Ophthalmology (1984) 1.63
Toxicity of intravitreous ceftazidime in primate retina. Arch Ophthalmol (1992) 1.63
Histopathology of commotio retinae. Retina (1992) 1.62
CD3+ CD8+ CTL activity within the human female reproductive tract: influence of stage of the menstrual cycle and menopause. J Immunol (1997) 1.62
Laser-induced drusen reduction improves visual function at 1 year. Choroidal Neovascularization Prevention Trial Research Group. Ophthalmology (1999) 1.61
Pneumocystis carinii choroiditis after long-term aerosolized pentamidine therapy. Am J Ophthalmol (1990) 1.57
Severe retinal vaso-occlusive disease in systemic lupus erythematous. Arch Ophthalmol (1986) 1.56
Asperillosis of the orbit. Report of ten cases and review of the literature. Arch Ophthalmol (1969) 1.56
The role of apoptosis in the pathogenesis of Fuchs endothelial dystrophy of the cornea. Arch Ophthalmol (2001) 1.56
Clinicopathologic correlation of surgically removed macular hole opercula. Am J Ophthalmol (1995) 1.55
Macular scatter ('grid') laser treatment of poorly demarcated subfoveal choroidal neovascularization in age-related macular degeneration. Results of a randomized pilot trial. Arch Ophthalmol (1996) 1.55
Frequency of adverse systemic reactions after fluorescein angiography. Results of a prospective study. Ophthalmology (1991) 1.54
Detection of human papillomavirus type 6/11 DNA in conjunctival papillomas by in situ hybridization with radioactive probes. Hum Pathol (1987) 1.54
The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol (1989) 1.53
Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc (1981) 1.52
The eye in bone marrow transplantation. VI. Retinal complications. Arch Ophthalmol (1994) 1.51
Bietti's crystalline dystrophy. A clinicopathologic correlative study. Arch Ophthalmol (1989) 1.51
The eye in bone marrow transplantation. I. Clinical study. Arch Ophthalmol (1983) 1.51
Ocular manifestations of graft-vs-host disease. Ophthalmology (1983) 1.50
Purtscher's-like retinopathy after childbirth. Ophthalmology (1990) 1.50
Pathologic myopia and choroidal neovascularization. Am J Ophthalmol (1981) 1.49
Histopathologic study of nine branch retinal vein occlusions. Arch Ophthalmol (1982) 1.48
Endophthalmitis due to Propionibacterium acnes sequestered between IOL optic and posterior capsule. Ophthalmic Surg (1989) 1.48
Frequency of ocular metastases in patients dying of cancer in eye bank populations. Br J Ophthalmol (1996) 1.46
Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophthalmology (1987) 1.46
Choroidal neovascularization as a late complication of ocular toxoplasmosis. Am J Ophthalmol (1981) 1.46
Granulomatous reaction to Bruch's membrane in age-related macular degeneration. Arch Ophthalmol (1994) 1.46
Idiopathic epiretinal membranes. Ultrastructural characteristics and clinicopathologic correlation. Ophthalmology (1989) 1.45
Oxidative damage in age-related macular degeneration. Histol Histopathol (2007) 1.44
No one knows the preferred management for choroidal melanoma. Am J Ophthalmol (1996) 1.44
Brown tumor of the orbit associated with primary hyperparathyroidism. Am J Ophthalmol (1980) 1.44
Massive hemorrhage complicating age-related macular degeneration. Clinicopathologic correlation and role of anticoagulants. Ophthalmology (1986) 1.44
Histopathologic features of idiopathic macular holes and cysts. Ophthalmology (1990) 1.43
Histopathologic studies of ischemic optic neuropathy. Trans Am Ophthalmol Soc (2000) 1.41
Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. J Clin Invest (1994) 1.41
Elevated intraocular pressure, pigment dispersion and dark hypopyon in endogenous endophthalmitis from Listeria monocytogenes. Surv Ophthalmol (1992) 1.41
Provision of anesthesia with single application of lidocaine 2% gel. J Cataract Refract Surg (1999) 1.40
Morphology, pathology, and surgery of idiopathic vitreoretinal macular disorders. A review. Retina (1990) 1.40
Visual abnormalities associated with high-energy microwave exposure. Retina (1993) 1.38
Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics. Am J Pathol (1989) 1.38
Central serous chorioretinopathy and pregnancy. Arch Ophthalmol (1993) 1.37
A histopathologic study of macular cysts and holes. Retina (1981) 1.36